RT Journal Article
SR Electronic
T1 Estimating body fat distribution – a driver of cardiometabolic health – from silhouette images
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.14.22269328
DO 10.1101/2022.01.14.22269328
A1 Marcus D. R. Klarqvist
A1 Saaket Agrawal
A1 Nathaniel Diamant
A1 Patrick T. Ellinor
A1 Anthony Philippakis
A1 Kenney Ng
A1 Puneet Batra
A1 Amit V. Khera
YR 2022
UL http://medrxiv.org/content/early/2022/01/16/2022.01.14.22269328.abstract
AB Background Inter-individual variation in fat distribution is increasingly recognized as clinically important but is not routinely assessed in clinical practice because quantification requires medical imaging.Objectives We hypothesized that a deep learning model trained on an individual’s body shape outline – or “silhouette” – would enable accurate estimation of specific fat depots, including visceral (VAT), abdominal subcutaneous (ASAT), and gluteofemoral (GFAT) adipose tissue volumes, and VAT/ASAT ratio. We additionally set out to study whether silhouette-estimated VAT/ASAT ratio may stratify risk of cardiometabolic diseases independent of body mass index (BMI) and waist circumference.Methods Two-dimensional coronal and sagittal silhouettes were constructed from whole-body magnetic resonance images in 40,032 participants of the UK Biobank and used to train a convolutional neural network to predict VAT, ASAT, and GFAT volumes, and VAT/ASAT ratio. Logistic and Cox regressions were used to determine the independent association of silhouette-predicted VAT/ASAT ratio with type 2 diabetes and coronary artery disease.Results Mean age of the study participants was 65 years and 51% were female. A deep learning model trained on silhouettes enabled accurate estimation of VAT, ASAT, and GFAT volumes (R2: 0.88, 0.93, and 0.93, respectively), outperforming a comparator model combining anthropometric and bioimpedance measures (ΔR2 = 0.05-0.13). Next, we studied VAT/ASAT ratio, a nearly BMI- and waist circumference-independent marker of unhealthy fat distribution. While the comparator model poorly predicted VAT/ASAT ratio (R2: 0.17-0.26), a silhouette-based model enabled significant improvement (R2: 0.50-0.55). Silhouette-predicted VAT/ASAT ratio was associated with increased prevalence of type 2 diabetes and coronary artery disease.Conclusions Body silhouette images can estimate important measures of fat distribution, laying the scientific foundation for population-based assessment.Competing Interest StatementM.D.R.K., N.D., A.P, and P.B. are supported by grants from Bayer AG applying machine learning in cardiovascular disease. S.A. has served as a scientific consultant to Third Rock Ventures. P.T.E. receives sponsored research support from Bayer AG and has consulted for Bayer AG, Novartis, MyoKardia and Quest Diagnostics. A.P. is also employed as a Venture Partner at GV and consulted for Novartis; and has received funding from Intel, Verily and MSFT. K.N. is an employee of IBM Research. P.B serves as a consultant for Novartis. A.V.K. is an employee and holds equity in Verve Therapeutics; has served as a scientific advisor to Amgen, Maze Therapeutics, Navitor Pharmaceuticals, Sarepta Therapeutics, Novartis, Silence Therapeutics, Korro Bio, Veritas International, Color Health, Third Rock Ventures, Illumina, Foresite Labs, and Columbia University (NIH); received speaking fees from Illumina, MedGenome, Amgen, and the Novartis Institute for Biomedical Research; and received a sponsored research agreement from IBM Research. Funding StatementThis work was supported by the Sarnoff Cardiovascular Research Foundation Fellowship (to S.A.), grants 1K08HG010155 and 1U01HG011719 (to A.V.K.) from the National Human Genome Research Institute, a Hassenfeld Scholar Award from Massachusetts General Hospital (to A.V.K.), a Merkin Institute Fellowship from the Broad Institute of MIT and Harvard (to A.V.K.), and a sponsored research agreement from IBM Research to the Broad Institute of MIT and Harvard (P.T.E., A.P., P.B., A.V.K.). M.D.R.K., S.A., P.B., and A.V.K. are listed as co-inventors on a patent application for the use of imaging data in assessing body fat distribution and associated cardiometabolic risk.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The raw UK Biobank data - including the anthropometric data reported here - are made available to researchers from universities and other research institutions with genuine research inquiries following IRB and UK Biobank approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe raw UK Biobank data - including the anthropometric data reported here - are made available to researchers from universities and other research institutions with genuine research inquiries following IRB and UK Biobank approval. Representative code used in this work will be deposited at the following Github repository: https://github.com/broadinstitute/ml4h/tree/master/model_zoo/silhouette_mri.